Open-label, multicentre, randomized clinical trial to compare the pharmacokinetics of ENVARSUS® tablets and ADVAGRAF® capsules administered once daily in adult de-novo kidney transplant patients.

Inclusion Criteria:

• Recipients of a kidney transplant from a deceased donor or a living donor

Exclusion Criteria:

• Recipient of any transplanted organ other than a kidney;
• Recipients of a bone marrow or stem cell transplant;
• Recipients of a kidney from a cardiac death donor;
• Recipients of a kidney from an ABO incompatible donor;